FDA Inspection 1051248 — Xellia (Taizhou) Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Xellia (Taizhou) Pharmaceuticals Co., Ltd. on Apr 6, 2018 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 6, 2018
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Taizhou (China)